STOCK TITAN

Mesoblast (MEOBF) Net Income by Year

MEOBF OTC

Mesoblast Ltd reported a net loss of $57.5M in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2016 to 2026, and the quarters Mesoblast Ltd has filed alongside them.

FY2026 annual
Net Income -$57.5M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (20-F/6-K) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MEOBF Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2620-FFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Net Income-$57.5Mn/m-$102.1Mn/m-$88.0Mn/m-$81.9Mn/m-$91.3Mn/m-$98.8Mn/m-$77.9Mn/m-$89.8Mn/m-$35.3Mn/m-$76.8Mn/m-$4.1M

MEOBF Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2620-FQ2'266-KQ4'256-KQ2'256-KQ4'2420-FQ2'246-KQ4'2320-FQ3'236-KQ2'236-KQ1'236-KQ4'2220-FQ3'226-K
Net IncomeN/AN/AN/AN/AN/AN/A-$21.9Mn/m-$18.6Mn/m-$24.5Mn/m-$16.9Mn/m-$21.5Mn/m-$21.3Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Mesoblast Ltd financials

Frequently Asked Questions

Mesoblast Ltd reported a net loss of $57.5M in fiscal year 2026.

Mesoblast Ltd (MEOBF) reported a $102.1M net loss in fiscal year 2025 and a $57.5M net loss in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 11 fiscal years this page covers, Mesoblast Ltd (MEOBF) net income went from -$4.1M in fiscal year 2016 to -$57.5M in fiscal year 2026.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Mesoblast Ltd (MEOBF) reported on that line in every period on record.